113 related articles for article (PubMed ID: 2167535)
1. Treatment of renal transplant-associated cytomegalovirus infection with ganciclovir.
Nicholson ML; Veitch PS; Donnelly PK; Flower AJ; Bell PR
Transplant Proc; 1990 Aug; 22(4):1811-2. PubMed ID: 2167535
[No Abstract] [Full Text] [Related]
2. Treatment of transplant rejection in the presence of cytomegalovirus viremia.
O'Hair DP; Johnson CP; Roza AM; Adams MB
Transplant Proc; 1990 Aug; 22(4):1815-7. PubMed ID: 2167537
[No Abstract] [Full Text] [Related]
3. Ganciclovir treatment for cytomegalovirus infections in renal transplant recipients.
Buturović-Ponikvar J; Kandus A; Malovrh M; Ponikvar R; Kveder R
Transplant Proc; 1992 Oct; 24(5):1921-3. PubMed ID: 1329287
[No Abstract] [Full Text] [Related]
4. Efficacy of early treatment of cytomegalovirus infection by ganciclovir in renal transplant recipients.
Rondeau E; Farquet C; Ruedin P; Fries D; Sraer JD
Transplant Proc; 1990 Aug; 22(4):1813-4. PubMed ID: 2167536
[No Abstract] [Full Text] [Related]
5. Analysis of cytomegalovirus reactivation after liver transplantation in cytomegalovirus immunoglobulin G antibody seropositive patients prior to transplantation.
Cuervas-Mons V; Garrido A; Barrios C; Portero F; de la Loma A; Albillos A; Ardaiz J; Turrión VS; Mora NP; Herrera J
Transplant Proc; 1990 Aug; 22(4):1798-9. PubMed ID: 2167530
[No Abstract] [Full Text] [Related]
6. Treatment of cytomegalovirus infections with gancyclovir during OKT3 administration.
Haberal M; Velidedoğlu E; Arslan G; Bilgin N; Büyükpamukçu N; Karamehmetoğlu M
Transplant Proc; 1995 Oct; 27(5):2707. PubMed ID: 7482883
[No Abstract] [Full Text] [Related]
7. The CARI guidelines. CMV disease and kidney transplant: treatment of cytomegalovirus disease in renal transplant recipients.
Caring for Australians with Renal Impairment (CARI)
Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S37-40. PubMed ID: 15469554
[No Abstract] [Full Text] [Related]
8. Cytomegalovirus prophylaxis in pediatric renal transplant recipients.
So S; Mayo C; McCullough C; Jendrisak M; Woodle S; Marsh W; Bailey T
Transplant Proc; 1993 Feb; 25(1 Pt 2):1414-5. PubMed ID: 8382865
[No Abstract] [Full Text] [Related]
9. Pilot study on induction treatment with high-dose OKT3: preliminary observations in kidney transplantation.
Welter HF; Illner WD; Schleibner S; Abendroth D; Hancke E; Groh J; Land W
Transplant Proc; 1990 Oct; 22(5):2272. PubMed ID: 2120813
[No Abstract] [Full Text] [Related]
10. Optimization of cyclosporine monotherapy--long-term graft function.
Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
Transplant Proc; 1994 Oct; 26(5):2501-6. PubMed ID: 7940767
[No Abstract] [Full Text] [Related]
11. Detection of cytomegalovirus infection under therapy with OKT3 monoclonal antibodies.
Müller T; Tolle S; Keuchel M; Schindler S; Hocke G; Steinmetz A; Beck J; Lange H
Transplant Proc; 1990 Aug; 22(4):1807-8. PubMed ID: 2167534
[No Abstract] [Full Text] [Related]
12. Preemptive therapy with gancyclovir for early high-risk CMV infection allows effective treatment with antithymocyte globulin of steroid-resistant rejection after renal transplantation.
van Son WJ; van den Berg AP; The TH; Tegzess AM
Transplant Proc; 1993 Feb; 25(1 Pt 2):1436-8. PubMed ID: 8382873
[No Abstract] [Full Text] [Related]
13. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
[TBL] [Abstract][Full Text] [Related]
14. The clinical application of a rapid diagnostic test for the detection of cytomegalovirus infection in renal transplant recipients.
Lui SF; Sweny P; Grundy JE; Blaxill A; Griffiths PD; Moorhead JF; Fernando ON
Transplant Proc; 1987 Feb; 19(1 Pt 3):2129-30. PubMed ID: 2856276
[No Abstract] [Full Text] [Related]
15. Cytomegalovirus infection in pediatric kidney transplantation.
Fontana I; Verrina E; Timitilli A; Arcuri V; Basile G; Losurdo G; Rabagliati AM; Perfumo F; Giacchino R; Gusmano R
Transplant Proc; 1994 Feb; 26(1):18-9. PubMed ID: 8108929
[No Abstract] [Full Text] [Related]
16. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus infection during OKT3 treatment for renal allograft rejection.
Morgan JD; Horsburgh T; Simpson A; Donnelly PK; Veitch PS; Bell PR
Transplant Proc; 1992 Dec; 24(6):2634-5. PubMed ID: 1334589
[No Abstract] [Full Text] [Related]
18. Treatment and prevention of cytomegalovirus in renal transplant patients: weighing the evidence.
Hakkert A; Dykeman-Sharpe J
CANNT J; 2003; 13(3):69-73; quiz 74-5. PubMed ID: 14596201
[No Abstract] [Full Text] [Related]
19. Successful treatment of Epstein-Barr virus infection with ganciclovir and cytomegalovirus hyperimmune globulin following kidney transplantation.
Delone P; Corkill J; Jordan M; Krapiva P; Ghasemian R; Sasaki T; Light JA
Transplant Proc; 1995 Oct; 27(5 Suppl 1):58-9. PubMed ID: 7482823
[No Abstract] [Full Text] [Related]
20. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
Ahsan N; Holman MJ; Yang HC
Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
